Evans We
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
-
- Acute Lymphoblastic Leukemia research
Papers in
- Pharmacology 11
- Pharmacogenetics and Drug Metabolism 11
- Antibiotics Pharmacokinetics and Efficacy 2
-
- Acute Lymphoblastic Leukemia research 23
- Co-authors
- Mary V. Relling (13 shared papers)Ching‐Hon Pui (10 shared papers)C‐H Pui (4 shared papers)Gaston K. Rivera (5 shared papers)FG Behm (2 shared papers)Charles B. Pratt (3 shared papers)Fatih Mehmet Uckun (6 shared papers)HL McLeod (2 shared papers)
- Journals
- Leukemia (8 papers)Clinical Pharmacology & Therapeutics (6 papers)Blood (5 papers)Journal of Clinical Oncology (2 papers)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Evans We
46 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 87
- Pharmacology 505
- Public Health, Environmental and Occupational Health 1.2k
- Hematology 251
- Transplantation 46
- Oncology 299
Countries citing papers authored by Evans We
This map shows the geographic impact of Evans We's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evans We with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evans We more than expected).
Fields of papers citing papers by Evans We
This network shows the impact of papers produced by Evans We. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evans We. The network helps show where Evans We may publish in the future.
Co-authors
The 25 scholars most cited alongside Evans We, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 242 | |
| 2 | 2003 | 201 | |
| 3 | 1995 | 190 | |
| 4 | 1996 | 186 | |
| 5 | 2008 | 185 | |
| 6 | 1994 | 168 | |
| 7 | 1998 | 160 | |
| 8 | 1997 | 151 | |
| 9 | 2012 | 100 | |
| 10 | 1994 | 93 | |
| 11 | 1992 | 84 | |
| 12 | 2010 | 79 | |
| 13 | 2015 | 77 | |
| 14 | 1998 | 76 | |
| 15 | 2000 | 74 | |
| 16 | 2012 | 73 | |
| 17 | Age-related adriamycin cardiotoxicity in children. | 1978 | 72 |
| 18 | Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St Jude total therapy study X. | 1992 | 70 |
| 19 | In vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor. | 1998 | 70 |
| 20 | Making TDM work to optimize cancer chemotherapy: a multidisciplinary team approach. | 1998 | 62 |
About Evans We
Evans We is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health, Oncology, Immunology and Transplantation, having authored 46 papers that have together received 3.1k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (23 papers), Pharmacogenetics and Drug Metabolism (11 papers), Toxin Mechanisms and Immunotoxins (5 papers), Cancer therapeutics and mechanisms (4 papers), Acute Myeloid Leukemia Research (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Pharmacology (505 citations), Public Health, Environmental and Occupational Health (1.2k citations), Hematology (251 citations), Transplantation (46 citations) and Oncology (299 citations). Evans We has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Mary V. Relling, Ching‐Hon Pui, C‐H Pui, Gaston K. Rivera, FG Behm, Charles B. Pratt, Fatih Mehmet Uckun, HL McLeod, Lisa M. Chelstrom and Yuri Yanishevski. Their work appears in journals such as Leukemia, Clinical Pharmacology & Therapeutics, Blood, Journal of Clinical Oncology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.